{{Rsnum
|rsid=1051169
|Gene=S100B
|Chromosome=21
|position=46602317
|Orientation=minus
|GMAF=0.4252
|Gene_s=S100B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 42.5 | 44.2 | 13.3
| HCB | 25.9 | 51.9 | 22.2
| JPT | 27.4 | 50.4 | 22.1
| YRI | 9.5 | 43.5 | 46.9
| ASW | 26.3 | 50.9 | 22.8
| CHB | 25.9 | 51.9 | 22.2
| CHD | 33.0 | 50.5 | 16.5
| GIH | 27.7 | 44.6 | 27.7
| LWK | 22.7 | 44.5 | 32.7
| MEX | 53.4 | 41.4 | 5.2
| MKK | 12.3 | 51.3 | 36.4
| TSI | 39.2 | 50.0 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=22019077
|Title=S100B gene polymorphisms predict prefrontal spatial function in both schizophrenia patients and healthy individuals
}}{{PMID Auto
|PMID=15670788
|Title=SNPs and haplotypes in the S100B gene reveal association with schizophrenia.
}}

{{PMID Auto
|PMID=19330775
|Title=Risk variants in the S100B gene predict elevated S100B serum concentrations in healthy individuals.
}}

{{PMID Auto
|PMID=20559426
|Title=Serum S100B: a potential biomarker for suicidality in adolescents?
|OA=1
}}

{{PMID Auto
|PMID=21070816
|Title=Risk variants in the S100B gene, associated with elevated S100B levels, are also associated with visuospatial disability of schizophrenia.
}}